[A Joint Investigation by the Gyeongnam Regional Center for Disease Control and Prevention and Local Goverments for Healthcare-associated Carbapenem Resistance in Busan]

【庆南地区疾病控制与预防中心与釜山地方政府联合开展的关于医疗机构相关碳青霉烯类耐药性的调查】

阅读:2

Abstract

There is an emerging concern about potential threats from antimicrobial drug abuse during the coronavirus disease 2019 pandemic. The rapid rise in the carbapenem-resistant Enterobacteriaceae (CRE) infection, one of the infectious diseases by antimicrobial drug-resistant microorganisms, has been observed since 2017 when full CRE case-reporting system was initiated in the Republic of Korea. Specially, Busan shows the highest CRE case numbers among non-metropolitan cities, which prompted the Gyeongnam Regional Center for Disease Control and Prevention to conduct a joint investigation with local government and institutions. The CRE isolates reported by 23 hospitals and 20 long-term care hospitals in Busan between June and December of 2022 were analyzed based on the reported case information. The environmental samples were also investigated to determine the facility infection control status. We found that the major CRE patient quarantine strategies (single-room vs. cohort) were different in the hospitals and long-term care hospitals. The study also evaluated the specific areas in facilities where the carbapenemase-producing microorganisms were found the most. These data are expected to be the basis of the infection control and prevention strategy development for the healthcare facilities in Busan. Furthermore this joint investigation is an example for a productive cooperation between the Korea Disease Control and Prevention Agency regional center and local government.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。